한국파마

032300KOSDAQ의약품 제조업

50.3 / 100

Reference Date: 2026-06-10

Financial Score15.0 / 40

News Sentiment21.3 / 25

Momentum4.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Plunged 21.9% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Hanok Pharma focuses on developing and selling prescription drugs for various disease areas such as the central nervous system and circulatory system through its own R&D. It expands its research in biopharmaceuticals and improved drugs via research centers in Daegu and Uijeongbu. Additionally, the company engages in CMO business, producing solid dosage forms and topical solutions, and is expanding its global market through exports and licensing-out deals.

Number of Employees

284people

Average Salary

67.6M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 11.934.0Point

PBR

1.37Industry Average 0.891.0Point

1.5x industry avg (risky)

ROE

-3.77Industry Average 4.010.0Point

Well below industry avg

Debt Ratio

1.87Industry Average 12.438.0Point

Half of industry avg (excellent)

Trend 2023~20252.0 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲2.7% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼58.8% (2-year basis)

ROE Trend

1.0 / 4

Avg ROE 0.6% (declining, 3yr)

Detailed News Sentiment

1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 85

Positive
한국파마, 1Q 영업익 13억원…전년比 57.2%↑
한국파마의 1분기 영업이익이 전년 대비 크게 증가하여 실적 개선을 보여주었다.

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 8,670Won52-week high 15,99052-week low 8,670

1-month return0.0Point

1m -21.89% (strong drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

6 totalPositive 0Neutral 6Negative 0

Neutral전환사채(해외전환사채포함)발행후만기전사채취득2026-05-28
Neutral증권발행결과(자율공시)2026-05-28
Neutral주식등의대량보유상황보고서(일반)2026-05-28
Neutral주요사항보고서(전환사채권발행결정)2026-05-20
Neutral분기보고서 (2026.03)2026-05-15